CBU
XENE icon

CIBC Bancorp USA’s Xenon Pharmaceuticals XENE Stock Holding History

CIBC Bancorp USA’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Buy
5,423
+1,074
+25% +$59.6K ﹤0.01% 1493
2026
Q1 		$253K Buy
+4,349
New +$200K ﹤0.01% 1494
2025
Q3 		$325K Buy
+8,100
New +$285K ﹤0.01% 1047

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Bancorp USA's XENE Position: Q2 2026 in Review

CIBC Bancorp USA increased its Xenon Pharmaceuticals (XENE) stake by 25% in Q2 2026, buying an estimated $59.6K and bringing the position to 5,423 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

CIBC Bancorp USA first reported a position in XENE in Q3 2025 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • CIBC Bancorp USA held 5,423 shares of Xenon Pharmaceuticals worth $327K as of Q2 2026.
  • CIBC Bancorp USA bought 1,074 Xenon Pharmaceuticals shares in Q2 2026, an estimated $59.6K.
  • Xenon Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1493 holding.
  • CIBC Bancorp USA first reported a position in Xenon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.